Longevity LifehacksEvidence Map
Interventions/Coffee & Caffeine
Diet & lifestyle · also: caffeine

Coffee & Caffeine

Coffee and caffeine intake are linked to lower dementia risk, possibly most for slow/intermediate caffeine metabolizers.

Summary

Debbie reviews population studies linking coffee and caffeine intake to lower dementia risk, with one study finding decaf had no effect, pointing to caffeine itself. A French cohort found the protective association only in people with slow or intermediate CYP1A2 caffeine metabolism, where four cups a day was tied to about 40% lower risk. She suggests possible mechanisms (nitric oxide in blood vessels, heat shock response) and pairs coffee with avoiding microplastics from disposable hot cups and plastic coffee makers, especially for APOE4 carriers.

Debbie's take
Daily coffee drinker: "As an intermediate caffeine metabolizer, my 2 - 3 cups of coffee habit could be a good thing." From Coffee Consumption and Dementia

The evidence

  • Human obs.

    In a French cohort of about 6,000 older adults followed for a median of 9 years, only slow or intermediate CYP1A2 caffeine metabolizers had lower dementia risk, from about 10% with one cup to about 40% with four cups daily.

  • Human obs.

    A meta-analysis of 750,000+ participants found dementia risk decreased linearly with tea intake and was lower with 1–3 cups of coffee per day.

  • Human obs.

    In a study of 2,500 older adults, caffeine intake of 266–495 mg/day was associated with about 40% lower dementia risk, while decaffeinated coffee had no statistical effect.

  • Human obs.

    In 587 people over age 90, consuming 200+ mg of caffeine per day was associated with 34% lower dementia risk than consuming under 50 mg/day.

  • Human obs.

    A July 2025 study found drinking 3+ cups of coffee was linked to over 40% lower Alzheimer's risk and possibly protection against Lewy body dementia.

  • Animal

    An analysis of caffeine studies reports caffeine is neuroprotective against dementia, including in animal models of Alzheimer's.

Doses used in studies

Amounts reported in the research, not dosing recommendations.

DoseContext
1–3 cups coffee/dayMeta-analysis of 750,000+ participants
1–4 cups coffee/dayFrench cohort; benefit only in slow/intermediate CYP1A2 metabolizers
266–495 mg caffeine/dayStudy of 2,500 older adults
200+ mg caffeine/day90+ Study (587 people over age 90)

Cautions

  • Late-day caffeine reduced her deep sleep and caused 3:30 am waking on a sleep tracker, so she stops by noon.
  • Jitteriness from caffeine likely has a genetic component (ADORA2A adenosine receptor variant).
  • Hot drinks in disposable cups, including plastic-lined paper coffee cups, release more microplastics; bring your own mug, or rinse a cup first to roughly halve microplastics.
  • Coffee makers that heat water in a plastic reservoir are a microplastics concern; she switched to a stainless steel kettle and French press.
  • During sleep deprivation, caffeine helped physical performance (rugby players) but significantly raised cortisol versus placebo, possibly more above normal intake.

Open questions

All human evidence is observational, the July 2025 study is uncited, and she questions whether the French CYP1A2 study accounted for smoking.